版本:
中国

BRIEF-Inovio's HIV vaccine produces nearly 100 pct immune response rates in clinical study

May 24 Inovio Pharmaceuticals Inc

* Inovio HIV vaccine elicits nearly 100% immune response rates in a clinical study

* Inovio Pharmaceuticals Inc - amongst evaluated participants receiving PENNVAX-GP and IL-12 via im vaccination, 27 of 27 demonstrated a cellular response Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐